Search For "drdo"
Our anti-drone technology can prevent Jammu Airbase like attacks: DRDO
Updated : 4 years, 8 months ago IST
New Delhi [India], July 2 (ANI): The counter-drone technology developed by Defence Research and Development Organisation (DRDO) could help Army swiftly detect and destroy drones that pose a security threat to the country.
Read More
DRDO successfully test-fires Agni-Prime missile
Updated : 4 years, 8 months ago IST
New Delhi [India], June 28 (ANI): India successfully carried out the test-firing of a new missile of the Agni series known as Agni-Prime off the coast of Odisha on Monday, said government sources.
Read More
Dr Reddy's Laboratories announces commercial launch of anti-COVID-19 drug
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], June 28 (ANI): Dr. Reddy's Laboratories Limited on Monday announced the commercial launch of 2-deoxy-D-glucose (2-DG), an anti-COVID-19 drug.
Read More
DRDO successfully test-fires indigenously-developed rockets off Odisha coa
Updated : 4 years, 9 months ago IST
New Delhi [India], June 25 (ANI): The Defence Research and Development Organisation (DRDO) on Friday announced that it has successfully test-fired enhanced range versions of indigenously developed Pinaka rockets and 122mm Caliber Rockets from a Multi-Barrel Rocket Launcher (MBRL) at Integrat
Read More
Grant announced for SDRF personnel deployed on COVID duty in Jammu
Updated : 4 years, 9 months ago IST
Jammu (Jammu and Kashmir) [India], June 17 (ANI): With the aim of boosting the morale of the State Disaster Response Force (SDRF) personnel deployed on COVID duty, the Director-General of Police DGP-cum-Commandant General of Home Guards/ Civil Defence and SDRF, VK Singh announced a grant and
Read More
Preliminary study claims DRDO's anti-COVID drug 2-DG effective against all
Updated : 4 years, 9 months ago IST
New Delhi [India], June 16 (ANI): A new study has claimed that DRDO's anti-COVID drug 2-DG is effective against all variants of COVID-19 and the drug reduces virus multiplication.
Read More
Two 250-bed makeshift COVID hospitals to be established in West Bengal thr
Updated : 4 years, 9 months ago IST
New Delhi [India], June 16 (ANI): The Prime Minister's Citizen Assistance and Relief in Emergency Situations (PM CARES) Fund Trust has allocated Rs 41.62 crores for the establishment of two 250 bedded makeshift COVID hospitals by DRDO at Murshidabad and Kalyani, West Bengal, informed the Pri
Read More
LG Manoj Sinha inaugurates 500-bedded DRDO Covid hospital in Srinagar
Updated : 4 years, 9 months ago IST
Srinagar (Jammu and Kashmir) [India], June 9 (ANI): Jammu and Kashmir Lieutenant Governor Manoj Sinha on Wednesday inaugurated a 500-bedded Defence Research and Development Organisation (DRDO) COVID-19 hospital with an ICU facility, at Khonmoh in Srinagar.
Read More
DRDO invites Expression of Interest for bulk production of COVID drug 2-DG
Updated : 4 years, 9 months ago IST
New Delhi [India], June 9 (ANI): The Defence Research and Development Organisation (DRDO), which developed 2 -Deoxy-D-Glucose (2-DG), a drug used for the treatment of COVID-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industr
Read More
J-K: Srinagar's 500 bed Covid-19 hospital in final stages of completion
Updated : 4 years, 9 months ago IST
Srinagar (Jammu and Kashmir) [India], June 3 (ANI): A 500-bed Covid-19 hospital in Khonmoh area of Srinagar is in final stages of completion and will soon be open to the public.
Read More
Uttarakhand CM inaugurates 500-bed COVID-19 Care Centre at Haldwani
Updated : 4 years, 9 months ago IST
Haldwani (Uttarakhand) [India], June 2 (ANI): Uttarakhand Chief Minister Tirath Singh Rawat on Wednesday virtually inaugurated a 500-bed COVID-19 Care Centre built by the Defence Research and Development Organisation (DRDO) in Haldwani.
Read More
2DG approved for emergency use as adjunct therapy for COVID-19 patients: D
Updated : 4 years, 9 months ago IST
New Delhi [India], June 1 (ANI): The Defence Research and Development Organisation's (DRDO) on Tuesday said that the anti-COVID drug 2DG is approved for emergency use as an adjunct therapy to the standard of care in the treatment of coronavirus patients in hospital settings.
Read More